{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:36Z","timestamp":1780426896968,"version":"3.54.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory disease, and dietary factors are associated with the onset and progression of IBD. The study aimed to investigate the causal association between some polyunsaturated fatty acids (PUFAs) and IBD, elucidating the nature of interactions occurring between them, and providing complementary guidance for clinical practice. Two-sample Mendelian randomization (MR) analysis was performed to elucidate the causal association between eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), linoleic acid (LA), and arachidonic acid (ARA) and IBD. These PUFAs and IBD were considered the exposure and outcome, respectively. The R TwoSampleMR package was used to conduct the analysis. We employed the weighted median method, weighted mode model, random effects inverse-variance weighted model, and MR-Egger method and observed no causal relationship between EPA, DPA, DHA, ARA, and LA and IBD, Crohn\u2019s disease (CD), and ulcerative colitis (UC). Furthermore, in reverse MR analysis, in which IBD, CD, and UC were the exposures and EPA, DPA, DHA, ARA, and LA were the outcomes, we observed no causal effect of IBD, CD, and UC on the investigated PUFAs. Finally, through independent genome-wide association studies, we validated concordant null causal effects of all PUFAs on IBD. Using MR, we systematically assess the causal effects of specific n\u22123 and n\u22126 PUFAs on IBD risk. Our results suggest no causal relationship between specific PUFAs (EPA, DPA, DHA, LA, and ARA) and IBD. Therefore, routine PUFA supplementation is unlikely to benefit IBD management and that single-PUFA intervention strategies lack a sound biological basis. Future studies should incorporate ancestry-matched genetic datasets to enhance generalizability, employ multi-omics approaches to investigate PUFAs metabolic pathways, and explore gene-environment interactions in PUFAs metabolism to further elucidate their potential role in IBD pathogenesis.<\/jats:p>","DOI":"10.1097\/md.0000000000044761","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:03:59Z","timestamp":1759248239000},"page":"e44761","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["No causal relationship between polyunsaturated fatty acids and inflammatory bowel disease: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Suyan","family":"Tian","sequence":"first","affiliation":[{"name":"Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Children\u2019s Hospital, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-109X","authenticated-orcid":false,"given":"Xiaoli","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Children\u2019s Hospital, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","article-title":"The burden of inflammatory bowel disease in Europe in 2020.","volume":"15","author":"Zhao","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults.","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of crohn\u2019s disease in adults.","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis.","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease.","volume":"6","author":"Roda","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mnfr.200700289","article-title":"Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.","volume":"52","author":"Calder","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.cgh.2018.01.036","article-title":"Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis.","volume":"16","author":"Scaioli","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/s41598-017-07992-1","article-title":"Short term treatment with eicosapentaenoic acid improves inflammation and affectscolonic differentiation markers and microbiota in patients with ulcerative colitis.","volume":"7","author":"Prossomariti","year":"2017","journal-title":"Sci Rep"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/apt.12670","article-title":"Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of crohn\u2019s disease.","volume":"39","author":"Chan","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1101305","article-title":"Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.","volume":"187","author":"Bento","year":"2011","journal-title":"J Immunol"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.1617290114","article-title":"Protectin D1 n-3 DPA and resolvin D5 n-3 DPA are effectors of intestinal protection.","volume":"114","author":"Gobbetti","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"G808","DOI":"10.1152\/ajpgi.00136.2015","article-title":"MAG-EPA reduces severity of DSS induced colitis in rats.","volume":"310","author":"Morin","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and infammatory processes: efects, mechanisms and clinical relevance.","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0148607103027003176","article-title":"Inhibition of activator protein-1 transcription factor activation by omega-3 fattacid modulation of mitogen-activated protein kinase signaling kinases.","volume":"27","author":"Babcock","year":"2003","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes:from molecules to man.","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/md17060374","article-title":"Effects of fish n-3 PUFAs on intestinal microbiota and immune system.","volume":"17","author":"Parolini","year":"2019","journal-title":"Mar Drugs"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00284-023-03482-y","article-title":"A potential role for gut microbes in mediating efects of omega-3 fatty acids in infammatory bowel diseases: a comprehensive review.","volume":"80","author":"Fard","year":"2023","journal-title":"Curr Microbiol"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in crohn\u2019s disease.","volume":"334","author":"Belluzzi","year":"1996","journal-title":"N Engl J Med"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.299.14.1690","article-title":"Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials.","volume":"299","author":"Feagan","year":"2008","journal-title":"JAMA"},{"key":"R20-20260602","first-page":"1","article-title":"Effects of omega-3 fatty acids on lipid and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus and osteoporosis.","volume":"89","author":"MacLean","year":"2004","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"R21-20260602","first-page":"CD006443","article-title":"Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.","author":"Turner","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20260602","first-page":"CD006320","article-title":"Omega 3 fatty acids (fish oil) for maintenance of remission in crohn\u2019s disease.","author":"Turner","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2013.12.034","article-title":"Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric crohn\u2019s disease.","volume":"146","author":"Costea","year":"2014","journal-title":"Gastroenterology"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gut.2008.169078","article-title":"Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case\u2013control study within a European prospective cohort study.","volume":"58","author":"Tjonneland","year":"2009","journal-title":"Gut"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ibd\/izy349","article-title":"A quantitative analysis of colonic mucosal oxylipins and endocannabinoids in treatment-na\u00efveand deep remission ulcerative colitis patients and the potential link with cytokine gene expression.","volume":"25","author":"Diab","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ibd.20094","article-title":"Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases.","volume":"13","author":"Jupp","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00365529509093234","article-title":"Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.","volume":"30","author":"Ikehata","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.crohns.2013.03.013","article-title":"Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.","volume":"8","author":"Pearl","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3945\/jn.109.119768","article-title":"An \u03b1-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-\u0138B in rats with TNBS-induced colitis.","volume":"140","author":"Hassan","year":"2010","journal-title":"J Nutr"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","article-title":"Long-term intake of dietary fat and risk of ulcerative colitis and crohn\u2019s disease.","volume":"63","author":"Ananthakrishnan","year":"2014","journal-title":"Gut"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3390\/nu14142883","article-title":"The effects of fatty acids on inflammatory bowel disease: a two-sample Mendelian randomization study.","volume":"14","author":"He","year":"2022","journal-title":"Nutrients"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"19273","DOI":"10.1038\/s41598-020-76361-2","article-title":"Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study.","volume":"10","author":"Carreras-Torres","year":"2020","journal-title":"Sci Rep"},{"key":"R34-20260602","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.3390\/ijms232214380","article-title":"Mendelian randomization indicates a causal role for omega-3 fatty acids in inflammatory bowel disease.","volume":"23","author":"Astore","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R35-20260602","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/metabo13101041","article-title":"Evaluating the effects of omega-3 polyunsaturated fatty acids on inflammatory bowel disease via circulating metabolites: a mediation Mendelian randomization study.","volume":"13","author":"Jia","year":"2023","journal-title":"Metabolites"},{"key":"R36-20260602","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR- Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R37-20260602","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","article-title":"An atlas of genetic influences on human blood metabolites.","volume":"46","author":"Shin","year":"2014","journal-title":"Nat Genet"},{"key":"R38-20260602","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA.","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"R39-20260602","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"R40-20260602","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.3390\/ijms20194851","article-title":"Omega fatty acids and inflammatory bowel diseases:an overview.","volume":"20","author":"Marton","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R41-20260602","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3390\/ijms18122619","article-title":"The imbalance between n-6\/n-3 polyunsaturated fatty acids and inflammatory bowel disease: a comprehensive review and future therapeutic perspectives.","volume":"18","author":"Scaioli","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R42-20260602","doi-asserted-by":"crossref","first-page":"539426","DOI":"10.1155\/2012\/539426","article-title":"Health implications of high dietary omega-6 polyunsaturated fatty acids.","volume":"2012","author":"Patterson","year":"2012","journal-title":"J Nutr Metab"},{"key":"R43-20260602","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ibd.21374","article-title":"Maintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses.","volume":"17","author":"Turner","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R44-20260602","first-page":"37","article-title":"Inflammatory bowel disease: can omega-3 fatty acids really help?","volume":"29","author":"Barbalho","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"R45-20260602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation.","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R46-20260602","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jand.2012.03.029","article-title":"Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials.","volume":"112","author":"Johnson","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"R47-20260602","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00394-020-02413-y","article-title":"Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials.","volume":"60","author":"Ajabnoor","year":"2021","journal-title":"Eur J Nutr"},{"key":"R48-20260602","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00054725-200502000-00009","article-title":"Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan.","volume":"11","author":"Sakamoto","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R49-20260602","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/s41598-019-39232-z","article-title":"Serum polyunsaturated fatty acids correlate with serum cytokines and clinical disease activity in crohn\u2019s disease.","volume":"9","author":"Scoville","year":"2019","journal-title":"Sci Rep"},{"key":"R50-20260602","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.5114\/aoms\/150041","article-title":"The risk of essential fatty acid insufficiency in patients with inflammatory bowel diseases: fatty acid profile of phospholipids in serum and in colon biopsy specimen.","volume":"18","author":"Bugajska","year":"2022","journal-title":"Arch Med Sci"},{"key":"R51-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2018.02.002","article-title":"Comprehensive genetic study of fatty acids helps explain the role of noncoding inflammatory bowel disease associated SNPs and fatty acid metabolism in disease pathogenesis.","volume":"130","author":"Jezernik","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R52-20260602","doi-asserted-by":"crossref","first-page":"293S","DOI":"10.3945\/an.114.006940","article-title":"The science of fatty acids and inflammation.","volume":"6","author":"Fritsche","year":"2015","journal-title":"Adv Nutr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:03:18Z","timestamp":1780423398000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":52,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044761","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-08-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}